XOMA Royalty (XOMA) Change in Accured Expenses (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Change in Accured Expenses came in at -$2.6 million in Q1 2026, up 19.51% year-on-year from -$2.2 million in Q1 2025, and up 64.24% quarter-over-quarter from -$7.3 million in Q4 2025.

XOMA Royalty (XOMA) Change in Accured Expenses (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$2.6 million for Q1 2026.

  • Change in Accured Expenses for Q1 2026 came in at -$2.6 million, up 19.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.0 million (down 537.64% YoY), and the FY2025 annual result was -$10.6 million, down 763.14% from the prior year.
  • Change in Accured Expenses came in at -$2.6 million for Q1 2026 at XOMA Royalty, up from -$7.3 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.1 million in Q1 2023 to a low of -$7.3 million in Q4 2025.
  • The 5-year median for Change in Accured Expenses is $31000.0 (2023), against an average of -$606176.5.
  • Across the five-year window, Change in Accured Expenses surged 9403.23% in 2024 and sank 3009.52% in 2025, its largest moves.
  • XOMA Royalty's Change in Accured Expenses stood at $1.2 million in 2022, then tumbled by 97.52% to $31000.0 in 2023, then soared by 9403.23% to $2.9 million in 2024, then tumbled by 349.46% to -$7.3 million in 2025, then soared by 64.24% to -$2.6 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$2.6 million (Q1 2026), -$7.3 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 931,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 70.50 Mn
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - -2.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.63 Mn
Mar 31, 2026 -2.63 Mn
Dec 31, 2025 -7.35 Mn
Dec 31, 2025 -7.35 Mn
Sep 30, 2025 -2.86 Mn
Sep 30, 2025 -2.86 Mn
Jun 30, 2025 2.88 Mn
Jun 30, 2025 2.88 Mn
Mar 31, 2025 -3.27 Mn
Mar 31, 2025 -3.27 Mn
Dec 31, 2024 2.95 Mn
Dec 31, 2024 2.95 Mn
Sep 30, 2024 -2.27 Mn
Sep 30, 2024 -2.27 Mn
Jun 30, 2024 1.03 Mn
Jun 30, 2024 1.03 Mn
Mar 31, 2024 -105,000.00
Mar 31, 2024 -105,000.00
Dec 31, 2023 31,000.00
Dec 31, 2023 31,000.00